<h3>Purpose</h3> Idiopathic pulmonary fibrosis (IPF) accounts for the largest proportion of diagnoses on the US lung transplant (LTx) list. LTx type (single vs double) and donor age are associated with differences in outcomes, yet their independent and combined effects in patients with IPF remain unclear and are investigated in this study. <h3>Methods</h3> This study retrospectively analyzed survival of patients with IPF receiving LTx at a single center from Feb-2012 to Mar-2020. LTx recipients were grouped by single (SLT) or double (DLT) LTx type and donor lung age <50 or 50≥ years. Survival outcomes were measured using Kaplan-Meier (KM) survival analysis and compared by log-rank test. Cox proportional hazards modeling was used to control for significantly associated variables, including lung allocation score, surgical approach, pump, warm ischemic time (avg), donor height, and prior percutaneous coronary intervention and coronary artery bypass grafting. <h3>Results</h3> Of 742 LTx patients, 305 (41%) were diagnosed with IPF, of which 204 (67%) were SLT and 97 (32%) were DLT (4 patients underwent either heart-lung transplant or single-sequential LTx and were excluded). There was no significant difference in survival due to LTx type (p=0.368). Similarly, no significant difference in survival was found for patients with donor age <50 or 50≥ years (p=0.298). Of grouped patients with IPF, there were 12 DLT and donor age 50≥, 35 SLT and donor age 50≥, 85 DLT and donor age <50, and 169 SLT and donor age <50. KM analysis showed no significant difference (p=0.455) in survival between the four groups, though DLT and donor age 50≥ had increased mean and median survival days comparatively. Cox regression suggested none of the covariates significantly affected survival. <h3>Conclusion</h3> Demand for donor lungs far exceeds supply, and with IPF accounting for a large percentage of this need, finding effective sources of supply has become increasingly important. Use of SLT and donors aged 50≥ can serve as important supply sources with non-inferior survival outcomes.